Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.

@article{Ogdie2017DefiningOM,
  title={Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.},
  author={Alexis Ogdie and Maarten de Wit and Kristina P Callis Duffin and Willemina Campbell and Jeffrey Cheuk Wai Chau and Laura C Coates and Lihi Eder and Musaab Elmamoun and Oliver FitzGerald and Dafna D Gladman and Niti Goel and Jana M James and Umut Kalyoncu and John J Latella and Chris Lindsay and Philip J Mease and Denis O'Sullivan and Ingrid Steinkoenig and Vibeke Strand and William S. Tillett and Ana-Maria Orbai},
  journal={The Journal of rheumatology},
  year={2017},
  volume={44 5},
  pages={
          697-700
        }
}
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Core Set working group recently published the updated 2016 psoriatic arthritis (PsA) core domain set, a set of disease features that should be measured in all clinical trials. At the GRAPPA annual meeting… CONTINUE READING